First evidence of SOX2 mutations in Peters' anomaly: Lessons from molecular screening of 95 patients

Peters' anomaly (PA) is a rare anterior segment dysgenesis characterized by central corneal opacity and irido‐lenticulo‐corneal adhesions. Several genes are involved in syndromic or isolated PA (B3GLCT, PAX6, PITX3, FOXE3, CYP1B1). Some copy number variations (CNVs) have also been occasionally reported. Despite this genetic heterogeneity, most of patients remain without genetic diagnosis. We retrieved a cohort of 95 individuals with PA and performed genotyping using a combination of comparative genomic hybridization, whole genome, exome and targeted sequencing of 119 genes associated with ocular development anomalies. Causative genetic defects involving 12 genes and CNVs were identified for 1/3 of patients. Unsurprisingly, B3GLCT and PAX6 were the most frequently implicated genes, respectively in syndromic and isolated PA. Unexpectedly, the third gene involved in our cohort was SOX2, the major gene of micro‐anophthalmia. Four unrelated patients with PA (isolated or with microphthalmia) were carrying pathogenic variants in this gene that was never associated with PA before. Here we described the largest cohort of PA patients ever reported. The genetic bases of PA are still to be explored as genetic diagnosis was unavailable for 2/3 of patients. Nevertheless, we showed here for the first time the involvement of SOX2 in PA, offering new evidence for its role in corneal transparency and anterior segment development.

[1]  E. Sorokina,et al.  Comprehensive phenotypic and functional analysis of dominant and recessive FOXE3 alleles in ocular developmental disorders , 2021, Human molecular genetics.

[2]  Y. Wakamatsu,et al.  The many faces of Sox2 function in neural crest development , 2020, Development, growth & differentiation.

[3]  Brenda L. Bohnsack,et al.  Genetics Underlying the Interactions between Neural Crest Cells and Eye Development , 2020, Journal of developmental biology.

[4]  D. Stephens,et al.  Long-Term Visual Outcomes and Clinical Course of Patients With Peters Anomaly. , 2020, Cornea.

[5]  P. Calvas,et al.  Confirmation of FZD5 implication in a cohort of 50 patients with ocular coloboma , 2020, European Journal of Human Genetics.

[6]  M. Cowley,et al.  Revealing hidden genetic diagnoses in the ocular anterior segment disorders , 2020, Genetics in Medicine.

[7]  Y. Shin,et al.  Effect of SOX2 Repression on Corneal Endothelial Cells , 2020, International journal of molecular sciences.

[8]  M. Tekin,et al.  Spectrum of Genetic Variants Associated with Anterior Segment Dysgenesis in South Florida , 2020, Genes.

[9]  G. Arno,et al.  The Spectrum of PAX6 Mutations and Genotype-Phenotype Correlations in the Eye , 2019, Genes.

[10]  E. Zackai,et al.  Novel variants in CDH2 are associated with a new syndrome including Peters anomaly , 2019, Clinical genetics.

[11]  J. Weiss,et al.  Clinical and genetic update of corneal dystrophies. , 2019, Experimental eye research.

[12]  Chen Luxenburg,et al.  SOX2 Regulates P63 and Stem/Progenitor Cell State in the Corneal Epithelium , 2019, Stem cells.

[13]  A. Levin,et al.  Ophthalmic manifestations associated with RARB mutations. , 2019, Clinical dysmorphology.

[14]  P. Calvas,et al.  Implication of non-coding PAX6 mutations in aniridia , 2018, Human Genetics.

[15]  J. Grigg,et al.  Phenotype–genotype correlations and emerging pathways in ocular anterior segment dysgenesis , 2018, Human Genetics.

[16]  S. Mundlos,et al.  Structural variation in the 3D genome , 2018, Nature Reviews Genetics.

[17]  Colin N. Dewey,et al.  Zebrafish zic2 controls formation of periocular neural crest and choroid fissure morphogenesis. , 2017, Developmental biology.

[18]  Y. Matsubara,et al.  SOX2 nonsense mutation in a patient clinically diagnosed with non-syndromic hypogonadotropic hypogonadism. , 2017, Endocrine journal.

[19]  J. Salazar,et al.  Goniodysgenesis variability and activity of CYP1B1 genotypes in primary congenital glaucoma , 2017, PloS one.

[20]  M. Brown,et al.  Contribution of Mutations in Known Mendelian Glaucoma Genes to Advanced Early-Onset Primary Open-Angle Glaucoma. , 2017, Investigative ophthalmology & visual science.

[21]  E. Weh,et al.  8q21.11 microdeletion in two patients with syndromic peters anomaly , 2016, American journal of medical genetics. Part A.

[22]  J. Escribano,et al.  Functional characterization of eight rare missense CYP1B1 variants involved in congenital glaucoma and their association with null genotypes , 2016, Acta ophthalmologica.

[23]  N. Katsanis,et al.  Targeted resequencing identifies PTCH1 as a major contributor to ocular developmental anomalies and extends the SOX2 regulatory network , 2016, Genome research.

[24]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[25]  R. Zori,et al.  A Case of 22q11.2 Deletion Syndrome with Peters Anomaly, Congenital Glaucoma, and Heterozygous Mutation in CYP1B1 , 2015, Ophthalmic genetics.

[26]  M. Maheshwari,et al.  Whole exome analysis identifies dominant COL4A1 mutations in patients with complex ocular phenotypes involving microphthalmia , 2014, Clinical genetics.

[27]  A. Toutain,et al.  Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia , 2014, Clinical genetics.

[28]  K. David,et al.  Whole exome sequence analysis of Peters anomaly , 2014, Human Genetics.

[29]  D. Bick,et al.  Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes , 2014, Clinical genetics.

[30]  G. Zaidman,et al.  Incidence of Peters Anomaly and Congenital Corneal Opacities Interfering With Vision in the United States , 2014, Cornea.

[31]  H. Wada,et al.  Mutation spectrum and phenotypic variation in nine patients with SOX2 abnormalities , 2014, Journal of Human Genetics.

[32]  A. Jauch,et al.  Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome , 2014, Orphanet Journal of Rare Diseases.

[33]  Margaret B. Fish,et al.  Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia. , 2013, American journal of human genetics.

[34]  D. Fitzpatrick,et al.  Clinical and mutation analysis of 51 probands with anophthalmia and/or severe microphthalmia from a single center , 2013, Molecular genetics & genomic medicine.

[35]  K. H. Shin,et al.  Comparison between aniridia with and without PAX6 mutations: clinical and molecular analysis in 14 Korean patients with aniridia. , 2012, Ophthalmology.

[36]  A. Sauer,et al.  [Axenfeld-Rieger syndrome]. , 2012, Journal francais d'ophtalmologie.

[37]  D. Lazzaro,et al.  Peters Anomaly: Review of the Literature , 2011, Cornea.

[38]  A. Cvekl,et al.  Retinoic acid signaling in mammalian eye development. , 2009, Experimental eye research.

[39]  D. Lacombe,et al.  Twelve new patients with 13q deletion syndrome: genotype-phenotype analyses in progress. , 2009, European journal of medical genetics.

[40]  G. Gole,et al.  Anterior segment mesenchymal dysgenesis in a large Australian family is associated with the recurrent 17 bp duplication in PITX3 , 2008, Molecular vision.

[41]  R. Lovell-Badge,et al.  SOX2 plays a critical role in the pituitary, forebrain, and eye during human embryonic development. , 2008, The Journal of clinical endocrinology and metabolism.

[42]  M. Harissi-Dagher,et al.  Anterior Segment Dysgenesis: Peters Anomaly and Sclerocornea , 2008, International ophthalmology clinics.

[43]  A. Wyatt,et al.  SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions , 2007, British Journal of Ophthalmology.

[44]  V. van Heyningen,et al.  Developmental malformations of the eye: the role of PAX6, SOX2 and OTX2 , 2006, Clinical genetics.

[45]  C. Hayward,et al.  Mutations in SOX2 cause anophthalmia , 2003, Nature Genetics.

[46]  B. Kerr,et al.  Domain disruption and mutation of the bZIP transcription factor, MAF, associated with cataract, ocular anterior segment dysgenesis and coloboma. , 2002, Human molecular genetics.

[47]  Y. Ogura,et al.  Histopathological examination of two cases of anterior staphyloma associated with Peters' anomaly and persistent hyperplastic primary vitreous , 2001, The British journal of ophthalmology.

[48]  I. Hanson,et al.  Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly , 1994, Nature Genetics.